Cellectar Biosciences, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.32x
Net debt / equity: -1.45x
Debt / assets: 0.14x
Debt / EBITDA: -0.07x
Net debt / EBITDA: 0.33x

Liquidity & coverage

Current ratio: 1.90x
Quick ratio: 1.90x
Cash ratio: 1.71x
Interest coverage: —
EBITDA / interest: —
Working capital: $4.4M

Cash & dividend

FCF / debt: -12.16x
Cash flow / debt: -12.15x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.